MATT DIXON
Head of M&A Lead Advisory, CCD Partners, London, United Kingdom

Abstract

This article is based on a talk, panel discussion, and networking event that took place in London in March 2023, co-hosted by corporate development consultancy CCD Partners and trans-Atlantic law firm Womble Bond Dickinson, in association with Women in Chemicals.

The typical acquisition process has several stages and having a disciplined process in place is paramount for success. It all starts with developing a compelling investment thesis to get the buy-in of investors and would-be targets alike. Next step is zeroing in on attractive targets by using a set of selection criteria and by developing a customized post deal business plan. It is important to engage with targets and develop positive, constructive relationships from the get-go in order to have the buy-in and support of sellers during deal making and later integration. Throughout, the buyer must not lose sight of the fundamental objective of the acquisition, namely value creation.

WHY ALL STRATEGIC LEADERS SHOULD BE CONSIDERING INORGANIC GROWTH STRATEGIES
Many sub-sectors of the chemicals and life sciences industries are driven by innovation, as entrepreneurial owner-managers launch new technologies / products and new services, vying to disrupt and reshape the market. Such sub-sectors are often highly fragmented and well-suited to buy-and-build strategies.Strategic leaders in such sub-sectors are often considering one or more of the ...